MANUSO JAMES S J 4

What Happened James S. Manuso, a director of TuHURA Biosciences, Inc. (HURA), received a grant of 156,240 derivative shares (reported as an award/option) on February 12, 2026. The filing shows an acquisition price of $0.00 (derivative instrument), and the award is governed by TuHURA’s 2024 Equity Incentive Plan. Footnotes describe vesting in thirds — one‑third becomes exercisable on each of the first, second and third anniversaries of February 12, 2026.

Key Details

• Transaction date: 2026-02-12; Filing date: 2026-02-17 (timely per Form 4 rules).
• Amount: 156,240 derivative shares granted; reported acquisition price $0.00.
• Vesting (per footnote F1): one‑third vests on each of the 1st, 2nd and 3rd anniversaries of Feb 12, 2026.
• Footnote F2 references a previously granted annual option (Jan 2, 2025) that vests one‑third on each anniversary of Jan 2, 2025.
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• Filing timeliness: filed within the required window (not marked late).

Context This is an equity award (derivative grant) to a director, not an open‑market purchase or sale. Such awards are commonly part of director compensation and vest over time; they do not by themselves indicate a buy/sell market signal. The $0.00 figure in the filing indicates no cash paid at grant in the reported line — consult the award agreement or company disclosures for exercise price, settlement mechanics, or whether the award is options versus restricted stock units.